CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease
Clinical trial NCT04091737 · TERMINATED
Trial details
- NCT number
- NCT04091737
- Sponsor
- CSL Behring
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2021-05-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.